SELLAS Life Sciences Grou... (SLS)

AI Score

Unlock

1.04

-0.06 (-5.45%)

At close: Apr 04, 2025, 3:59 PM

1.06

1.90%

After-hours: Apr 04, 2025, 05:49 PM EDT

SELLAS Life Sciences Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006
Cash & Equivalents	13.99M	2.53M	17.13M	21.36M	35.3M	7.28M	5.34M	2.32M	18.08M	29.73M	23.65M	47.79M	32.81M	11.43M	6.89M	5.68M	9.86M	1.76M	2K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.68M	n/a	n/a	n/a	n/a	9.95M	n/a
Long-Term Investments	n/a	n/a	-184K	-152K	-1.15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	74K	3K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	266K	275K	399K	594K	614K	536K	-765K	925K	96K	171K	87K	115K	74K	13.26M	16K	16K	16K	66K	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	308K	n/a	n/a	n/a	n/a	1.84M	3.68M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	465K	573K	n/a	n/a	n/a	-19.51M	655K	386K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.34M	499K	330K	1.44M	1.35M	184K	291K	10.43M	85K	22.49M	1.64M	200K	101K	101K	n/a	n/a	n/a	n/a	n/a
Total Current Assets	16.33M	3.17M	17.76M	23.04M	36.92M	8.24M	5.84M	13.09M	37.5M	53.62M	29.02M	53.45M	36.12M	11.81M	7.04M	5.8M	9.93M	11.74M	2K
Property-Plant & Equipment	925K	858K	874K	723K	896K	217K	n/a	n/a	199K	335K	555K	665K	29K	393K	419K	432K	414K	344K	n/a
Goodwill & Intangibles	1.91M	1.91M	1.91M	1.91M	7.61M	7.61M	10.41M	19.51M	28.02M	28.02M	50.82M	33.74M	18.76M	18.76M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.1M	3.05M	3.19M	3.23M	9.12M	8.37M	11.08M	20.44M	28.31M	28.52M	51.46M	34.52M	18.86M	19.16M	435K	448K	430K	410K	n/a
Total Assets	19.43M	6.22M	20.94M	26.27M	46.05M	16.61M	16.91M	33.53M	65.81M	82.14M	80.49M	87.98M	54.99M	30.97M	7.48M	6.25M	10.36M	12.15M	2K
Account Payables	3.5M	5.64M	3.36M	2.14M	4.66M	3.9M	3.75M	11.69M	n/a	1.6M	2.27M	2.66M	1.98M	2.15M	724K	625K	394K	55K	n/a
Deferred Revenue	n/a	n/a	n/a	2.48M	5.6M	n/a	n/a	4.31M	5.24M	30.29M	15.67M	8.67M	935K	816K	1.11M	1.08M	974K	n/a	n/a
Short-Term Debt	544K	n/a	372K	198K	166K	217K	n/a	8.38M	1.71M	4.74M	3.91M	2.15M	6K	500K	51K	52K	17K	n/a	n/a
Other Current Liabilities	1.82M	6.16M	9.97M	952K	935K	389K	8K	1.49M	2.01M	24.2M	18.85M	55.63M	11.18M	6.31M	3.46M	4.09M	428K	884K	n/a
Total Current Liabilities	9.51M	13.73M	15.52M	4.98M	12.34M	5.29M	5.97M	24.57M	30.4M	57.07M	27.23M	62.45M	15.92M	11.2M	5.03M	5.47M	1.39M	1.32M	n/a
Long-Term Debt	457K	n/a	n/a	n/a	n/a	n/a	n/a	2.61M	5.66M	n/a	4.49M	7.74M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	4K	336K	4.69M	4.96M	5.34M	2.6M	-5.66M	6.14M	6.65M	6.82M	6.21M	4.57M	n/a	n/a	0.00	n/a	n/a
Total Long-Term Liabilities	457K	460K	577K	946K	5.75M	5.23M	5.7M	6.89M	6.76M	11.56M	16.2M	19.64M	11.31M	9.65M	20K	36K	4K	n/a	n/a
Total Liabilities	9.97M	14.2M	16.09M	5.93M	18.09M	10.52M	11.67M	31.46M	37.15M	68.63M	43.43M	82.09M	27.23M	20.86M	5.05M	5.51M	1.39M	1.32M	n/a
Total Debt	1M	906K	945K	808K	991K	217K	n/a	10.99M	16.4M	4.74M	8.4M	9.92M	57K	567K	71K	88K	21K	n/a	n/a
Common Stock	7K	3K	2K	2K	1K	5K	2K	1K	15K	15K	12K	10K	8K	5K	2K	2K	1K	1K	n/a
Retained Earnings	-248.13M	-217.24M	-179.9M	-138.6M	-117.9M	-101.15M	-81.86M	-54.19M	-302.93M	-279.38M	-215.48M	-178.88M	-102.2M	-67.23M	-55.74M	-43.75M	-25.36M	-10.99M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	0.00	n/a	n/a	n/a	n/a	1.63M	-657K	-491K	-320K	-158K	n/a	n/a
Shareholders Equity	9.46M	-7.98M	4.85M	20.35M	27.96M	6.09M	5.25M	2.07M	28.66M	13.51M	37.06M	5.89M	27.76M	10.11M	2.43M	741K	8.97M	10.82M	2K
Total Investments	n/a	-1	-184K	-152K	-1.15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.75M	3K	n/a	n/a	n/a	9.95M	n/a